The 1-year results from the PRECISE Trial were presented at the American Heart Association (AHA) annual congress in Chicago on November 6th. This global, prospective, randomised trial examined a Precision Pathway versus a Traditional Testing pathway for patients with stable chest pain.

Shaping the future of healthcare

Smart technologies are often touted as the answer to some of cardiology’s greatest challenges in patient care and practice. Randy Young | Artificial Intelligence | AI in Healthcare

Seimens go beyond digital with the game changer in PET/CT. Introducing Biograph Vision.

By detecting high-risk plaque, coronary CT angiography (CCTA) can predict major adverse cardiovascular events in patients with stable chest pain, according to a January 10 study in JAMA Cardiology. But the jury is still out on whether CCTA findings should be... By Brian Casey, AuntMinnie.com staff writer